ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,542.56
0.02%
Dow Jones
40,813.57
-1.30%
Gold vs US Dollar
2,987.92
1.70%
Brent Oil
69.925
-1.08%
Bitcoin
81,101.87
-3.04%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Ligand Pharmaceuticals Incorporated (LGND)

  7. Ligand Pharmaceuticals Incorporated (LGND) News

Ligand Pharmaceuticals (LGND)

Ligand Pharmaceuticals Incorporated
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:LGND
DateTimeSourceHeadlineSymbolCompany
06/03/202523:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LGNDLigand Pharmaceuticals Incorporated
06/03/202523:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LGNDLigand Pharmaceuticals Incorporated
06/03/202523:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LGNDLigand Pharmaceuticals Incorporated
03/03/202512:00GlobeNewswire Inc.Ligand to Participate in March Investor ConferencesNASDAQ:LGNDLigand Pharmaceuticals Incorporated
27/02/202512:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LGNDLigand Pharmaceuticals Incorporated
27/02/202512:00GlobeNewswire Inc.Ligand Reports Fourth Quarter and Full Year 2024 Financial ResultsNASDAQ:LGNDLigand Pharmaceuticals Incorporated
25/02/202512:00GlobeNewswire Inc.Ligand Leads $75 Million Royalty Financing in Castle Creek BiosciencesNASDAQ:LGNDLigand Pharmaceuticals Incorporated
13/02/202512:00Business WireLigand to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025NASDAQ:LGNDLigand Pharmaceuticals Incorporated
06/02/202512:00Business WireLigand to Present at the Oppenheimer 35th Annual Healthcare Life Sciences ConferenceNASDAQ:LGNDLigand Pharmaceuticals Incorporated
10/12/202414:00Business WireLigand Hosts 2024 Investor and Analyst Day and Introduces 2025 GuidanceNASDAQ:LGNDLigand Pharmaceuticals Incorporated
07/12/202400:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LGNDLigand Pharmaceuticals Incorporated
03/12/202401:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LGNDLigand Pharmaceuticals Incorporated
27/11/202421:44Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LGNDLigand Pharmaceuticals Incorporated
14/11/202420:19Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:LGNDLigand Pharmaceuticals Incorporated
14/11/202413:00Business WireLigand to Present at Stifel 2024 Healthcare ConferenceNASDAQ:LGNDLigand Pharmaceuticals Incorporated
12/11/202415:25Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LGNDLigand Pharmaceuticals Incorporated
08/11/202422:34Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:LGNDLigand Pharmaceuticals Incorporated
08/11/202421:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LGNDLigand Pharmaceuticals Incorporated
17/10/202411:30GlobeNewswire Inc.Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial OfficerNASDAQ:LGNDLigand Pharmaceuticals Incorporated
26/09/202400:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LGNDLigand Pharmaceuticals Incorporated
24/09/202423:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LGNDLigand Pharmaceuticals Incorporated
24/09/202423:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LGNDLigand Pharmaceuticals Incorporated
23/09/202421:30Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LGNDLigand Pharmaceuticals Incorporated
23/09/202421:27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LGNDLigand Pharmaceuticals Incorporated
31/08/202401:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LGNDLigand Pharmaceuticals Incorporated
31/08/202400:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LGNDLigand Pharmaceuticals Incorporated
28/08/202420:39Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LGNDLigand Pharmaceuticals Incorporated
27/08/202400:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LGNDLigand Pharmaceuticals Incorporated
22/08/202422:05Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:LGNDLigand Pharmaceuticals Incorporated
13/08/202421:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LGNDLigand Pharmaceuticals Incorporated
 Showing the most relevant articles for your search:NASDAQ:LGND

Your Recent History

TG
VTM
Altius Minerals
TG
8NI
Nikola
TG
ECF
Mountain Alliance
TG
FSV
Colliers
LSE
TMR
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2025 ADVFN PLC - All Rights Reserved

    Go Ad-Free

    Subscribe to Ad free and enjoy an ad-free experience

    No Ads

    Try Now

    Keep the Ads